Bivalirudin overdose: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
Line 1: Line 1:
{{CMG}}
Adverse reactions have not been reported; however, monitor for signs of bleeding.
Adverse reactions have not been reported; however, monitor for signs of bleeding.


{{FDA}}
{{FDA}}

Latest revision as of 18:53, 14 July 2011

Adverse reactions have not been reported; however, monitor for signs of bleeding.

Adapted from the FDA Package Insert.